We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
-18.26%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$859M
AUM Growth
-$274M
Cap. Flow
+$11.4M
Cap. Flow %
1.32%
Top 10 Hldgs %
49.67%
Holding
76
New
1
Increased
28
Reduced
18
Closed
5

Top Buys

Rank Stock Value
1
NEO icon
NeoGenomics
NEO
+$18.2M
2
SIBN icon
SI-BONE Inc
SIBN
+$15.4M
3
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$13.1M
4
ATRC icon
AtriCure
ATRC
+$5.44M
5
AXGN icon
Axogen
AXGN
+$5.14M

Top Sells

Rank Stock Value
1
HALO icon
Halozyme
HALO
+$28.4M
2
XENT
Intersect ENT, Inc
XENT
+$19.6M
3
STRO icon
Sutro Biopharma
STRO
+$13.7M
4
KRYS icon
Krystal Biotech
KRYS
+$7.61M
5
BCYC
Bicycle Therapeutics
BCYC
+$3.92M

Sector Composition

Rank Sector Weight
1 Healthcare 86.58%
2 Communication Services 8.2%
3 Energy 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MODN
1
DELISTED
MODEL N, INC.
MODN
$70.4M 8.2%
2,753,758
+46,615
+2% +$1.16M
ATRC icon
2
AtriCure
ATRC
$1.92B
$60.5M 7.03%
1,479,626
+114,814
+8% +$5.44M
PRTA icon
3
Prothena Corp
PRTA
$425M
$52.6M 6.12%
1,938,183
+99,635
+5% +$2.91M
HALO icon
4
Halozyme
HALO
$9.79B
$41.4M 4.82%
941,245
-656,284
-41% -$28.4M
SPNE
5
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$39.7M 4.62%
7,030,309
+24,521
+0.4% +$214K
OMCL icon
6
Omnicell
OMCL
$1.61B
$39.5M 4.59%
347,029
+25,267
+8% +$2.9M
KRYS icon
7
Krystal Biotech
KRYS
$10.1B
$39.1M 4.55%
595,612
-122,324
-17% -$7.61M
CUTR
8
DELISTED
Cutera, Inc.
CUTR
$28.9M 3.37%
771,814
-2,413
-0.3% -$127K
TNDM icon
9
Tandem Diabetes Care
TNDM
$1.34B
$27.7M 3.22%
467,555
+32,250
+7% +$2.65M
RARE icon
10
Ultragenyx Pharmaceutical
RARE
$2.45B
$27M 3.14%
452,470
+14,958
+3% +$920K
SIBN icon
11
SI-BONE Inc
SIBN
$788M
$26.5M 3.08%
2,006,304
+921,670
+85% +$15.4M
AXGN icon
12
Axogen
AXGN
$2.27B
$24.8M 2.88%
3,025,119
+601,784
+25% +$5.14M
CRNX icon
13
Crinetics Pharmaceuticals
CRNX
$8.84B
$23.1M 2.69%
1,240,609
+657,842
+113% +$13.1M
BLU
14
DELISTED
BELLUS Health Inc.
BLU
$22.3M 2.59%
2,408,074
-83,269
-3% -$681K
NEO icon
15
NeoGenomics
NEO
$1.96B
$22.1M 2.58%
2,715,487
+1,909,529
+237% +$18.2M
FNA
16
DELISTED
Paragon 28, Inc.
FNA
$19.6M 2.29%
1,237,511
+118,908
+11% +$2M
ATEC icon
17
Alphatec Holdings
ATEC
$1.46B
$19.1M 2.23%
2,924,964
+206,844
+8% +$1.91M
AXNX
18
DELISTED
Axonics, Inc. Common Stock
AXNX
$17.8M 2.07%
314,004
+34,494
+12% +$1.89M
CDNA icon
19
CareDx
CDNA
$2.26B
$16.7M 1.94%
776,620
+54,547
+8% +$1.51M
KROS icon
20
Keros Therapeutics
KROS
$199M
$16.5M 1.92%
598,333
-59,812
-9% -$2.62M
HCAT icon
21
Health Catalyst
HCAT
$154M
$16.4M 1.91%
1,135,165
+276,432
+32% +$4.71M
KRTX
22
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$15.9M 1.85%
125,793
+8,924
+8% +$1.03M
KRMD icon
23
KORU Medical Systems
KRMD
$189M
$15.4M 1.8%
6,102,934
+3,114
+0.1% +$7.56K
INSM icon
24
Insmed
INSM
$21.4B
$15M 1.75%
762,182
+24,388
+3% +$511K
NGM
25
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$14.6M 1.69%
1,135,884
+319,231
+39% +$4.42M
1
2 3 4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, First Light Asset Management held 76 positions worth $859M, down 24% from $1.13B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

First Light Asset Management's Q2 2022 filing shows 1 new, 28 increased, 18 reduced and 5 closed positions. Its largest new stake was iShares Russell 2000 Growth ETF: 13,242 shares worth $2.73M. The largest sale was Halozyme, an estimated $28.4M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 84% a quarter earlier, followed by Communication Services and Energy.

  • First Light Asset Management's largest Q2 2022 buy was iShares Russell 2000 Growth ETF: 13,242 shares worth $2.73M.
  • First Light Asset Management added most to NeoGenomics in Q2 2022, an estimated $18.2M increase.
  • First Light Asset Management's biggest Q2 2022 reduction was Halozyme, cutting an estimated $28.4M.
  • First Light Asset Management fully exited Intersect ENT, Inc in Q2 2022, selling an estimated $19.6M.
  • First Light Asset Management's ten largest holdings make up 50% of its $859M portfolio in Q2 2022.
  • First Light Asset Management opened 1 new position and closed 5 in Q2 2022.
  • First Light Asset Management's portfolio value fell 24% quarter-over-quarter to $859M.

Based on First Light Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.